查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1968382

人工智慧（AI）市場分析及2035年醫療保健產業預測：按類型、產品、服務、技術、組件、應用、最終用戶、部署、解決方案和模式分類

AI in Healthcare Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, End User, Deployment, Solutions, Mode
出版日期: | 出版商: Global Insight Services | 英文 456 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計到2034年，醫療保健領域的人工智慧市場規模將從2024年的160億美元成長至8,568億美元，複合年成長率約為48.9%。該市場涵蓋將人工智慧技術融入醫療保健領域，以改善診斷、治療方案製定和患者管理。透過利用機器學習、自然語言處理和機器人技術，該領域正在推動臨床療效和營運效率的提升。對個人化醫療和預測分析日益成長的需求正在推動市場成長，並促進疾病檢測、藥物研發和虛擬醫療助理領域的創新。

受機器學習和數據分析技術進步的推動，醫療保健領域的人工智慧市場預計將迎來強勁成長。在該領域，臨床試驗板塊正透過利用人工智慧技術提升患者招募效率和簡化數據分析流程，實現領先成長。放射學領域也緊隨其後，人工智慧驅動的影像解決方案提高了診斷的準確性和效率。預測分析子板塊發展勢頭強勁，為醫療服務提供者提供可操作的洞察，以改善患者照護並提升營運效率。虛擬助理和聊天機器人的日益普及有助於簡化病人參與和行政管理工作。人工智慧演算法驅動的個人化醫療正在變革治療通訊協定，實現根據個別基因譜量身定做的干涉措施。人工智慧驅動的藥物發現也是一個前景廣闊的領域，能夠加速潛在化合物的識別並縮短上市時間。隨著人工智慧不斷融入醫療保健系統，倫理考量和資料隱私仍然至關重要，需要建立健全的框架來確保合規性和信任。

市場區隔
類型 機器學習、自然語言處理、電腦視覺、機器人流程自動化
產品 人工智慧驅動的穿戴式裝置、診斷系統、治療設備和虛擬助理。
服務 臨床工作流程支援、預測分析、遠端監控、資料管理
科技 深度學習、神經網路、認知運算、情境感知處理
成分 軟體、硬體和服務
目的 病患管理、藥物研發、醫學影像、基因組學
最終用戶 醫院、診所、研究機構、醫療保健提供者
發展 雲端部署、本地部署、混合部署
解決方案 病患資料分析、臨床試驗、社區醫療保健管理、詐欺檢測
模式 全自動、半自動、手動

市場概況：

在對可擴展、靈活的醫療數據管理的需求驅動下，醫療保健領域的人工智慧正在經歷快速發展，其中基於雲端的解決方案佔據了相當大的市場佔有率。定價策略競爭激烈，符合醫療服務提供者成本效益目標的價值導向模式正日益受到青睞。近期發布的產品專注於提高診斷準確性和個人化醫療，體現了該行業對創新的堅定承諾。北美地區繼續引領人工智慧的應用，但亞太地區投資的激增凸顯了其作為主要參與者的新興潛力。競爭基準分析顯示，IBM、微軟和谷歌等公司憑藉其技術實力和策略夥伴關係關係處於行業領先地位。北美和歐洲的法規結構至關重要，嚴格的資料隱私法影響市場動態。遵守醫療標準的需求進一步塑造了市場格局，並影響著人工智慧的應用策略。儘管面臨資料安全和整合複雜性等挑戰，但市場前景依然光明，人工智慧驅動的預測分析和精準醫療有望推動成長。

主要趨勢和促進因素：

受個人化醫療和先進診斷技術需求不斷成長的推動，醫療保健領域的人工智慧市場正經歷強勁成長。關鍵趨勢包括人工智慧與遠端醫療平台的日益整合，從而改善遠端患者監護和醫療服務品質。穿戴式健康設備的普及也加速了人工智慧的應用，透過即時數據分析和預測性洞察，能夠改善患者預後。醫療保健領域巨量資料分析的興起是另一個重要促進因素，它能夠實現更精準的疾病預測和治療方案製定。此外，人工智慧驅動的機器人手術也備受關注，因為它能夠實現精準手術並縮短恢復時間。監管支援和政府主導的人工智慧應用推廣措施也促進了市場擴張。開發用於慢性病管理的人工智慧解決方案蘊藏著許多機遇，有助於應對糖尿病和心血管疾病等慢性病日益沉重的負擔。專注於人工智慧驅動的藥物發現和開發的公司能夠更好地發揮市場潛力。此外，科技公司與醫療服務提供者之間的合作正在推動創新，並為變革性的醫療保健解決方案鋪平道路。隨著行業的不斷發展，在技術進步和對以患者為中心的護理日益重視的推動下，醫療領域的人工智慧市場預計將持續成長。

壓制與挑戰：

人工智慧在醫療保健領域的市場目前面臨許多重大限制和挑戰。其中一個主要挑戰是嚴格的法規環境。遵守醫療保健法規和標準既複雜又耗時，往往導致人工智慧應用的延遲。資料隱私問題也是一個主要障礙。在利用人工智慧技術的同時保護病患資訊需要強大的安全措施，而這些措施成本高且技術難度高。此外，熟練專業人員的短缺也是一大挑戰。將人工智慧融入醫療保健需要同時具備技術和醫學方面的專業知識，而這類人才目前十分稀缺。高昂的實施成本也是阻礙市場成長的因素之一。人工智慧技術所需的初始投資可能成為許多醫療保健機構的障礙。最後，醫療產業內部存在著變革阻力。傳統方法根深蒂固，對新技術的接受度普遍較低，這可能會減緩人工智慧的普及速度。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章：細分市場分析

  • 市場規模及預測：依類型
    • 機器學習
    • 自然語言處理
    • 電腦視覺
    • 機器人流程自動化
  • 市場規模及預測：依產品分類
    • 人工智慧驅動的穿戴式設備
    • 診斷系統
    • 治療設備
    • 虛擬助手
  • 市場規模及預測：依服務分類
    • 臨床工作流程支持
    • 預測分析
    • 遠端監控
    • 資料管理
  • 市場規模及預測：依技術分類
    • 深度學習
    • 神經網路
    • 認知運算
    • 情境感知處理
  • 市場規模及預測：依組件分類
    • 軟體
    • 硬體
    • 服務
  • 市場規模及預測：依應用領域分類
    • 病患管理
    • 藥物發現
    • 醫學影像
    • 基因組學
  • 市場規模及預測：依最終用戶分類
    • 醫院
    • 診所
    • 研究機構
    • 醫療保健提供者
  • 市場規模及預測：依市場細分
    • 基於雲端的
    • 現場
    • 混合
  • 市場規模及預測：按解決方案分類
    • 患者數據分析
    • 臨床試驗
    • 人口健康管理
    • 詐欺偵測
  • 市場規模及預測：按模式
    • 自動的
    • 半自動
    • 手動的

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章：公司簡介

  • Zebra Medical Vision
  • Tempus
  • PathAI
  • Qventus
  • Viz.ai
  • Aidoc
  • Butterfly Network
  • Babylon Health
  • Proscia
  • Owkin
  • Freenome
  • SOPHiA GENETICS
  • HeartFlow
  • Atomwise
  • Deep Genomics
  • Insilico Medicine
  • CureMetrix
  • Arterys
  • Recursion Pharmaceuticals
  • Enlitic

第9章 關於我們

簡介目錄
Product Code: GIS33043

AI in Healthcare Market is anticipated to expand from $16 billion in 2024 to $856.8 billion by 2034, growing at a CAGR of approximately 48.9%. The AI in Healthcare Market encompasses the integration of artificial intelligence technologies within medical practices, enhancing diagnostics, treatment planning, and patient management. This sector leverages machine learning, natural language processing, and robotics to improve clinical outcomes and operational efficiency. Rising demand for personalized medicine and predictive analytics is propelling market growth, fostering innovations in disease detection, drug discovery, and virtual health assistants.

The AI in Healthcare Market is poised for robust growth, propelled by advancements in machine learning and data analytics. Within this landscape, the clinical trials segment emerges as a top performer, leveraging AI to enhance patient recruitment and streamline data analysis. Radiology follows closely, with AI-driven imaging solutions improving diagnostic accuracy and efficiency. The predictive analytics sub-segment is gaining momentum, offering healthcare providers actionable insights for patient care and operational efficiency. Virtual assistants and chatbots are also witnessing increased adoption, enhancing patient engagement and administrative functions. Personalized medicine, powered by AI algorithms, is transforming treatment protocols, tailoring interventions to individual genetic profiles. AI-driven drug discovery is another promising area, accelerating the identification of potential compounds and reducing time-to-market. As AI continues to integrate into healthcare systems, ethical considerations and data privacy remain critical, necessitating robust frameworks to ensure compliance and trust.

Market Segmentation
TypeMachine Learning, Natural Language Processing, Computer Vision, Robotic Process Automation
ProductAI-Powered Wearables, Diagnostic Systems, Therapeutic Devices, Virtual Assistants
ServicesClinical Workflow Assistance, Predictive Analytics, Remote Monitoring, Data Management
TechnologyDeep Learning, Neural Networks, Cognitive Computing, Context-Aware Processing
ComponentSoftware, Hardware, Services
ApplicationPatient Management, Drug Discovery, Medical Imaging, Genomics
End UserHospitals, Clinics, Research Institutes, Healthcare Providers
DeploymentCloud-Based, On-Premises, Hybrid
SolutionsPatient Data Analysis, Clinical Trials, Population Health Management, Fraud Detection
ModeAutomated, Semi-Automated, Manual

Market Snapshot:

AI in Healthcare is witnessing a dynamic evolution with significant market share held by cloud-based solutions, driven by the demand for scalable and flexible healthcare data management. Pricing strategies remain competitive, with value-based models gaining traction as they align with healthcare providers' cost-efficiency goals. Recent product launches focus on enhancing diagnostic accuracy and personalized medicine, reflecting the industry's commitment to innovation. North America continues to lead in adoption, while Asia-Pacific's investment surge highlights its emerging potential as a key player. Competitive benchmarking reveals that companies like IBM, Microsoft, and Google are at the forefront, leveraging their technological prowess and strategic partnerships. Regulatory frameworks in North America and Europe are pivotal, with stringent data privacy laws influencing market dynamics. The landscape is further shaped by the need for compliance with healthcare standards, impacting AI deployment strategies. The market's trajectory is promising, with AI-driven predictive analytics and precision medicine expected to catalyze growth, despite challenges like data security and integration complexities.

Geographical Overview:

The AI in Healthcare market is witnessing remarkable growth across various regions, each characterized by unique dynamics. North America leads, driven by advanced healthcare infrastructure and substantial investments in AI technologies. The presence of major tech companies and healthcare institutions is fostering innovation and adoption. Europe follows, with strong emphasis on AI research and development, supported by government initiatives and funding. This region's commitment to data privacy enhances market attractiveness. In Asia Pacific, rapid expansion is driven by technological advancements and significant investments in AI healthcare solutions. The growing population and increasing healthcare demands further fuel this growth. Latin America and the Middle East & Africa are emerging as promising markets. In Latin America, rising investments in healthcare infrastructure and AI technologies are evident. Meanwhile, the Middle East & Africa are recognizing AI's potential in transforming healthcare services, enhancing efficiency and accessibility, and driving economic growth.

Key Trends and Drivers:

The AI in Healthcare Market is experiencing robust growth, fueled by the increasing demand for personalized medicine and advanced diagnostics. Key trends include the integration of AI with telemedicine platforms, enhancing remote patient monitoring and care delivery. The proliferation of wearable health devices is also driving AI adoption, enabling real-time data analysis and predictive insights for better patient outcomes. The rise of big data analytics in healthcare is another significant driver, allowing for more accurate disease prediction and treatment planning. Additionally, AI-powered robotic surgeries are gaining traction, offering precision and reduced recovery times. Regulatory support and government initiatives promoting AI adoption in healthcare further bolster market expansion. Opportunities abound in the development of AI solutions for chronic disease management, addressing the growing burden of conditions such as diabetes and cardiovascular diseases. Companies focusing on AI-driven drug discovery and development are well-positioned to capitalize on the market's potential. Moreover, partnerships between tech firms and healthcare providers are fostering innovation, paving the way for transformative healthcare solutions. As the industry evolves, the AI in Healthcare Market is poised for sustained growth, driven by technological advancements and an increasing focus on patient-centric care.

Restraints and Challenges:

The AI in Healthcare Market is currently facing several notable restraints and challenges. One significant challenge is the stringent regulatory environment. Compliance with healthcare regulations and standards is complex and time-consuming, often delaying AI implementation. Data privacy concerns also pose a major obstacle. Protecting patient information while utilizing AI technologies requires robust security measures, which can be costly and technically challenging. Additionally, there is a shortage of skilled professionals. The integration of AI into healthcare demands expertise in both technology and medical fields, which is currently lacking. High implementation costs further hinder market growth. The initial investment required for AI technologies can be prohibitive for many healthcare providers. Lastly, there is a resistance to change within the healthcare industry. Traditional practices are deeply ingrained, and there is often skepticism towards adopting new technologies, which can slow down AI adoption.

Key Players:

Zebra Medical Vision, Tempus, PathAI, Qventus, Viz.ai, Aidoc, Butterfly Network, Babylon Health, Proscia, Owkin, Freenome, SOPHiA GENETICS, HeartFlow, Atomwise, Deep Genomics, Insilico Medicine, CureMetrix, Arterys, Recursion Pharmaceuticals, Enlitic

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Deployment
  • 2.9 Key Market Highlights by Solutions
  • 2.10 Key Market Highlights by Mode

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Machine Learning
    • 4.1.2 Natural Language Processing
    • 4.1.3 Computer Vision
    • 4.1.4 Robotic Process Automation
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 AI-Powered Wearables
    • 4.2.2 Diagnostic Systems
    • 4.2.3 Therapeutic Devices
    • 4.2.4 Virtual Assistants
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Clinical Workflow Assistance
    • 4.3.2 Predictive Analytics
    • 4.3.3 Remote Monitoring
    • 4.3.4 Data Management
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Deep Learning
    • 4.4.2 Neural Networks
    • 4.4.3 Cognitive Computing
    • 4.4.4 Context-Aware Processing
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Software
    • 4.5.2 Hardware
    • 4.5.3 Services
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Patient Management
    • 4.6.2 Drug Discovery
    • 4.6.3 Medical Imaging
    • 4.6.4 Genomics
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Hospitals
    • 4.7.2 Clinics
    • 4.7.3 Research Institutes
    • 4.7.4 Healthcare Providers
  • 4.8 Market Size & Forecast by Deployment (2020-2035)
    • 4.8.1 Cloud-Based
    • 4.8.2 On-Premises
    • 4.8.3 Hybrid
  • 4.9 Market Size & Forecast by Solutions (2020-2035)
    • 4.9.1 Patient Data Analysis
    • 4.9.2 Clinical Trials
    • 4.9.3 Population Health Management
    • 4.9.4 Fraud Detection
  • 4.10 Market Size & Forecast by Mode (2020-2035)
    • 4.10.1 Automated
    • 4.10.2 Semi-Automated
    • 4.10.3 Manual

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 End User
      • 5.2.1.8 Deployment
      • 5.2.1.9 Solutions
      • 5.2.1.10 Mode
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 End User
      • 5.2.2.8 Deployment
      • 5.2.2.9 Solutions
      • 5.2.2.10 Mode
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 End User
      • 5.2.3.8 Deployment
      • 5.2.3.9 Solutions
      • 5.2.3.10 Mode
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 End User
      • 5.3.1.8 Deployment
      • 5.3.1.9 Solutions
      • 5.3.1.10 Mode
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 End User
      • 5.3.2.8 Deployment
      • 5.3.2.9 Solutions
      • 5.3.2.10 Mode
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 End User
      • 5.3.3.8 Deployment
      • 5.3.3.9 Solutions
      • 5.3.3.10 Mode
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 End User
      • 5.4.1.8 Deployment
      • 5.4.1.9 Solutions
      • 5.4.1.10 Mode
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 End User
      • 5.4.2.8 Deployment
      • 5.4.2.9 Solutions
      • 5.4.2.10 Mode
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 End User
      • 5.4.3.8 Deployment
      • 5.4.3.9 Solutions
      • 5.4.3.10 Mode
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 End User
      • 5.4.4.8 Deployment
      • 5.4.4.9 Solutions
      • 5.4.4.10 Mode
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 End User
      • 5.4.5.8 Deployment
      • 5.4.5.9 Solutions
      • 5.4.5.10 Mode
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 End User
      • 5.4.6.8 Deployment
      • 5.4.6.9 Solutions
      • 5.4.6.10 Mode
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 End User
      • 5.4.7.8 Deployment
      • 5.4.7.9 Solutions
      • 5.4.7.10 Mode
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 End User
      • 5.5.1.8 Deployment
      • 5.5.1.9 Solutions
      • 5.5.1.10 Mode
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 End User
      • 5.5.2.8 Deployment
      • 5.5.2.9 Solutions
      • 5.5.2.10 Mode
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 End User
      • 5.5.3.8 Deployment
      • 5.5.3.9 Solutions
      • 5.5.3.10 Mode
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 End User
      • 5.5.4.8 Deployment
      • 5.5.4.9 Solutions
      • 5.5.4.10 Mode
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 End User
      • 5.5.5.8 Deployment
      • 5.5.5.9 Solutions
      • 5.5.5.10 Mode
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 End User
      • 5.5.6.8 Deployment
      • 5.5.6.9 Solutions
      • 5.5.6.10 Mode
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 End User
      • 5.6.1.8 Deployment
      • 5.6.1.9 Solutions
      • 5.6.1.10 Mode
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 End User
      • 5.6.2.8 Deployment
      • 5.6.2.9 Solutions
      • 5.6.2.10 Mode
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 End User
      • 5.6.3.8 Deployment
      • 5.6.3.9 Solutions
      • 5.6.3.10 Mode
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 End User
      • 5.6.4.8 Deployment
      • 5.6.4.9 Solutions
      • 5.6.4.10 Mode
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 End User
      • 5.6.5.8 Deployment
      • 5.6.5.9 Solutions
      • 5.6.5.10 Mode

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Zebra Medical Vision
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Tempus
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 PathAI
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Qventus
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Viz.ai
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Aidoc
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Butterfly Network
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Babylon Health
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Proscia
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Owkin
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Freenome
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 SOPHiA GENETICS
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 HeartFlow
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Atomwise
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Deep Genomics
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Insilico Medicine
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 CureMetrix
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Arterys
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Recursion Pharmaceuticals
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Enlitic
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us